Bhatia Kishor G.
SEC insider (Form 3/4/5 filer). CIK 0001812638. Chief Scientific Officer at Lantern Pharma Inc. (LTRN). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 18, 2025. Located in DALLAS, TX.
Companies Bhatia Kishor G. has filed insider reports for
- Lantern Pharma Inc. (LTRN): Officer, Chief Scientific Officer
Bhatia Kishor G.
CIK: 0001812638
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lantern Pharma Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 18, 2025LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
10K shares- - Oct 29, 2021LTRN
Lantern Pharma Inc.
DispositionDirectStock Option (Right to Buy)
17.4K shares- - Oct 29, 2021LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
17.4K shares- - Jun 15, 2020LTRN
Lantern Pharma Inc.
DispositionDirectStock Option (Right to Buy)
52.2K shares- - Jun 15, 2020LTRN
Lantern Pharma Inc.
AwardDirectStock Option (Right to Buy)
52.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 18, 2025 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | Disposition Stock Option (Right to Buy) | 17,400 | - | - | Direct |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 17,400 | - | - | Direct |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | Disposition Stock Option (Right to Buy) | 52,200 | - | - | Direct |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | Award Stock Option (Right to Buy) | 52,200 | - | - | Direct |
1-5 of 5 transactions